Resource Logo

HIV-antibody testing in France. results of a national survey.


Int Conf AIDS. 1990 Jun 20-23;6(3):120 (abstract no. S.C.97). Unique

OBJECTIVE: to determine the variations of prevalence of HIV-antibody (HIV-ab) testing in France according to sociodemographical characteristics and risk behaviors. METHODS: a national sample of 2294 subjects of the 16-50 population in France was administered a special anonymous questionnaire investigating attitudes towards health, knowledge and risk behaviors related to AIDS. The response rate was 82%. RESULTS: Among the male adult population (N = 1506) and the female adult population (N = 788), respectively 13% and 12% have received HIV-ab testing. Singles have been significantly more tested (16%) than the rest of the population (r=5%, p less than 0.05). The prevalence of HIV-ab testing peaks in the 25-29 year age group in males (19%) and in the 21-24 year age group in females (21%). Regional prevalences of testing and AIDS cases are highly correlated. There are strong relationships between the prevalence of testing and the presence of risk factors. In males, the HIV-ab prevalence reaches 22% in homosexuals, 24% in the heterosexuals reporting sexual relationship with prostitutes and 41% in those reporting IV drug use in the last 5 years. Testing is strongly correlated with the number of partners: 24% in males and 28% in females reporting more than 4 partners during the last 5 years. CONCLUSION: the strong relationship found between the risky behaviors and the prevalence of HIV-ab testing suggests that the high risk group for AIDS are more likely to receive the testing. The results also encourage the policy of non-compulsory confidential testing.

Acquired Immunodeficiency Syndrome/DIAGNOSIS/*EPIDEMIOLOGY Adult Attitude to Health Confidentiality Female France/EPIDEMIOLOGY Health Policy Homosexuality Human HIV/*IMMUNOLOGY HIV Antibodies/*ANALYSIS HIV Seroprevalence Male Prostitution Questionnaires Risk Factors Sexual Partners Substance Abuse, Intravenous ABSTRACT


Information in this article was accurate in December 30, 1990. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.